The alkaline single cell electrophoresis assay with eight mouse organs: results with 22 mono-functional alkylating agents (including 9 dialkyl N-nitrosoamines) and 10 DNA crosslinkers
S. Tsuda et al., The alkaline single cell electrophoresis assay with eight mouse organs: results with 22 mono-functional alkylating agents (including 9 dialkyl N-nitrosoamines) and 10 DNA crosslinkers, MUT RES-GTE, 467(1), 2000, pp. 83-98
Citations number
36
Categorie Soggetti
Molecular Biology & Genetics
Journal title
MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS
The genotoxicity of 22 mono-functional alkylating agents (including 9 dialk
yl N-nitrosoamines) and 10 DNA crosslinkers selected from IARC (Internation
al Agency for Research on Cancer) groups 1, 2A, and 2B was evaluated in eig
ht mouse organs with the alkaline single cell gel electrophoresis (SCGE) (c
omet) assay. Groups of four mice were treated once intraperitoneally at the
dose at which micronucleus tests had been conducted, and the stomach, colo
n, liver, kidney, bladder, lung, brain, and bone marrow were sampled 3, 8,
and/or 24 h later. All chemicals were positive in the SCGE assay in at leas
t one organ. Of the 22 mono-functional alkylating agents, over 50% were pos
itive in all organs except the brain and bone marrow. The two subsets of mo
no-functional alkylating agents differed in their bone marrow genotoxicity:
only 1 of the 9 dialkyl N-nitrosoamines was positive in bone marrow as opp
osed to 8 of the 13 other alkylating agents, reflecting the fact that dialk
yl N-nitrosoamines are poor micronucleus inducers in hematopoietic cells. T
he two groups of mono-functional alkylating agents also differ in hepatic c
arcinogenicity in spite of the fact that they are similar in hepatic genoto
xicity. While dialkyl N-nitrosoamines produce tumors primarily in mouse liv
er, only one (styrene-7,8-oxide) out of 10 of the other type of mono-functi
onal alkylating agents is a mouse hepatic carcinogen. Taking into considera
tion our previous results showing high concordance between hepatic genotoxi
city and carcinogenicity for aromatic amines and azo compounds, a possible
explanation for the discrepancy might be that chemicals that require metabo
lic activation show high concordance between genotoxicity and carcinogenici
ty in the liver. A high percent of the 10 DNA crosslinkers were positive in
the SCGE assay in the gastrointestinal mucosa, but less than 50% were posi
tive in the liver and lung. In this study, we allowed 10 min alkali-unwindi
ng to obtain low,md stable control values. Considering that DNA crosslinkin
g lesions can be detected as lowering of not only positive but also negativ
e control values, low control values by short alkali-treatment might make i
t difficult to detect DNA crosslinking lesions. In conclusion, although bot
h mono-functional alkylating agents and DNA crosslinkers are genotoxic in m
ouse multiple organs, the genotoxicity of DNA crosslinkers can be detected
in the gastrointestinal organs even though they were given intraperitoneall
y followed by the short alkali-treatment. (C) 2000 Published by Elsevier Sc
ience B.V. All rights reserved.